Related Experiment Video
Updated: Jun 11, 2025
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
85.8K
Neonatal Clinical Pharmacology.
Karel Allegaert1,2,3, Nadir Yalcin4, Robert B Flint3,5,6
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
Children (Basel, Switzerland)
|September 28, 2024
Summary
Neonatal pharmacotherapy requires specific guidance on drug formulation, dosing, and safety for infants. Evidence-based recommendations are crucial for optimizing treatment and ensuring positive health outcomes in newborns.
Area of Science:
- Neonatal pharmacotherapy
- Pediatric pharmacology
- Evidence-based medicine
Background:
- Neonatal care necessitates specialized pharmacotherapy guidelines.
- Effective neonatal pharmacotherapy requires age-appropriate formulations and individualized dosing.
- Evaluating drug efficacy and safety in neonates is critical for clinical practice.
Discussion:
- Robust guidance is essential for safe and effective neonatal drug use.
- Individualized dosing strategies are paramount in neonatal pharmacotherapy.
- Consideration of alternative therapeutic approaches is important in neonatal care.
Key Insights:
- Neonatal pharmacotherapy demands tailored approaches.
- Comprehensive guidance enhances drug efficacy and safety in neonates.
- Individualized treatment plans are vital for this vulnerable population.
Outlook:
- Future research should focus on developing specific neonatal drug formulations.
- Further investigation into comparative effectiveness of neonatal pharmacotherapies is needed.
- Standardized guidelines will improve the quality of neonatal care globally.
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
01:19Nonlinear Pharmacokinetics: Overview
302
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
302
01:28Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
102
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
102
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K